Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)

Hagerman, Paul J (PI)

Biochemistry and Molecular Medicine

Project: Research project

Project Details

Status	Finished
Effective start/end date	9/30/07 → 6/30/12

Funding

National Institutes of Health: $792,986.00
National Institutes of Health: $793,447.00
National Institutes of Health: $860,314.00
National Institutes of Health: $74,991.00
National Institutes of Health: $787,990.00
National Institutes of Health: $798,611.00

View all

View less

ASJC

Medicine(all)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.